Cintas Corporation
224.10USD
+0.0600 (+0.03%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CTAS.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.36▲ | $1.36 | 6 | 2 |
| Next quarter | $1.34▼ | $1.37 | 2 | 9 |
| Current year | $5.54▲ | $5.48 | 14 | 0 |
| Next year | $6.16▲ | $6.09 | 13 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-08-31 | $1.35 | $1.39 | +0.04 (+3.0%) |
| 2026-05-31 | $1.24 | $1.29 | +0.05 (+4.0%) |
| 2026-02-28 | $1.24 | $1.24 | +0.00 (+0.1%) |
| 2025-11-30 | $1.2 | $1.21 | +0.01 (+1.0%) |
248 ratings from 28 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Citigroup | Maintained | Sell | $180 $181 | Sep 30, 2026 |
| Argus Research | Maintained | Buy | $230 $240 | Sep 29, 2026 |
| UBS | Maintained | Buy | $230 $235 | Sep 24, 2026 |
| Baird | Maintained | Outperform | $214 $222 | Sep 24, 2026 |
| Truist Securities | Maintained | Buy | $225 $230 | Sep 24, 2026 |
| RBC Capital | Reiterated | Sector Perform | $206 | Sep 24, 2026 |
| Citigroup | Maintained | Sell | $175 $180 | Sep 22, 2026 |
| Argus Research | Maintained | Buy | $220 $230 | Jul 17, 2026 |
| UBS | Maintained | Buy | $228 $230 | Jul 16, 2026 |
| Wells Fargo | Maintained | Overweight | $245 $250 | Jul 16, 2026 |
| RBC Capital | Reiterated | Sector Perform | $206 | Jul 16, 2026 |
| Baird | Maintained | Outperform | $200 $214 | Jul 16, 2026 |
| B of A Securities | Upgraded from Neutral | Buy | $200 $230 | Jul 16, 2026 |
| B of A Securities | Maintained | Neutral | $215 $200 | Jun 29, 2026 |
| Truist Securities | Maintained | Buy | $255 $225 | Jun 15, 2026 |
| Citigroup | Maintained | Sell | $181 $160 | Mar 31, 2026 |
| Stifel | Maintained | Hold | $222 $190 | Mar 26, 2026 |
| Wells Fargo | Upgraded from Equal-Weight | Overweight | $205 $245 | Jan 14, 2026 |
| Citigroup | Maintained | Sell | $176 $181 | Dec 22, 2025 |
| UBS | Maintained | Buy | $255 $235 | Dec 19, 2025 |
| RBC Capital | Reiterated | Sector Perform | $206 | Dec 19, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $185 $205 | Dec 19, 2025 |
| Baird | Maintained | Neutral | $220 $225 | Dec 19, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $220 $210 | Dec 17, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $218 $185 | Nov 25, 2025 |
47 filings from 15 insiders · 7 buy / 2 sell over 6m
Officers and directors of CTAS, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| TYSOE RONALD WDirector | GrantPhantom Stock Units | 101.52 | $198.95 | $20k | Sep 15, 2026 |
| Coletti Robert E.Director | GrantPhantom Stock Units | 29.71 | $198.95 | $6k | Sep 15, 2026 |
| CARNAHAN KAREN LDirector | GrantPhantom Stock Units | 17.82 | $198.95 | $4k | Sep 15, 2026 |
| Barstad Melanie W.Director | GrantPhantom Stock Units | 12.37 | $198.95 | $2k | Sep 15, 2026 |
| ROZAKIS JAMESPresident | Grant | 11.3k | $202.71 | $2.28M | Aug 10, 2026 |
| FARMER SCOTT DOfficer and Director | Grant | 830 | $202.71 | $168k | Aug 10, 2026 |
| SCHNEIDER TODD MChief Executive Officer | Grant | 57.9k | $202.71 | $11.75M | Aug 10, 2026 |
| DENTON DAVID BROCKGeneral Counsel | Grant | 5.7k | $202.71 | $1.16M | Aug 10, 2026 |
| GARULA SCOTTChief Financial Officer | Grant | 10.7k | $202.71 | $2.17M | Aug 10, 2026 |
| TYSOE RONALD WILLIAMDirector | Exercise | 5.0k | $27.10 | $137k | Jul 22, 2026 |
| TYSOE RONALD WILLIAMDirector | Sell | 4.4k | $199.90 | $872k | Jul 22, 2026 |
| BARSTAD MELANIE WDirector | Exercise | 10.5k | $27.10 | $286k | Jul 16, 2026 |
| BARSTAD MELANIE WDirector | Sell | 9.1k | $202.94 | $1.86M | Jul 16, 2026 |
| TYSOE RONALD WILLIAMDirector | Exercise | 5.5k | $27.10 | $149k | Apr 20, 2026 |
| TYSOE RONALD WILLIAMDirector | Sell | 4.7k | $178.87 | $835k | Apr 20, 2026 |
| COLETTI ROBERT EDirector | Exercise | 12.5k | $26.86 | $339k | Apr 9, 2026 |
| COLETTI ROBERT EDirector | Gift | 5.2k | — | — | Jan 28, 2026 |
| FARMER SCOTT DOfficer, Director and Beneficial Owner | Gift | 10.4k | — | — | Jan 28, 2026 |
| COLETTI ROBERT EOfficer and Director | Gift | 14.0k | — | — | Dec 23, 2025 |
| FARMER SCOTT DOfficer, Director and Beneficial Owner | Gift | 29.0k | — | — | Dec 23, 2025 |
No analyst notes on CTAS yet.
Analyst Ratings
16 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 8 | 9 | 1 | 0 | Buy2.45 |
| 1 mo ago | 2 | 8 | 9 | 1 | 0 | Buy2.45 |
| 2 mo ago | 2 | 8 | 9 | 1 | 0 | Buy2.45 |
| 3 mo ago | 2 | 8 | 9 | 1 | 0 | Buy2.45 |
Members whose judged calls on CTAS have played out most reliably.
No settled calls on CTAS yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice